SNTI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Senti Biosciences, Inc (SNTI) is not a strong buy for a beginner investor with a long-term strategy. The stock lacks clear positive catalysts, shows weak financial performance, and has no significant trading signals or institutional interest. Given the investor's preference for long-term stability, it is better to hold off on investing in this stock for now.
The technical indicators suggest a bearish trend. The MACD is below 0 and contracting negatively, RSI is neutral at 49.253, and the moving averages are bearish with SMA_200 > SMA_20 > SMA_5. Key support and resistance levels indicate the stock is trading near its support at 0.789, with resistance levels at 0.92 and 0.961.
NULL identified. The stock has no recent positive news or trading signals.
The company reported a Q4 EPS of -$0.53, missing estimates, and revenue of only $22,000, raising concerns about profitability and future funding needs. Financials show a YoY decline in net income (-100%) and no significant revenue growth.
In Q4 2025, the company reported a revenue of $22,000 with no YoY growth. Net income dropped by 100% YoY, and EPS improved to -2.73 but remains negative. Gross margin remained at 0%. Overall, the financial performance is weak and concerning.
No recent analyst ratings or price target changes are available.
